Crinetics Pharmaceuticals, Inc. (CRNX)

Healthcare · Biotechnology · NASDAQ

Crinetics Pharmaceuticals, Inc. (CRNX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $8.92B and a free-cash-flow yield of -4.8%. Over the most recent reported fiscal year, revenue grew 640.7%.

Market cap	$8.92B
Trailing P/E	—
FCF yield	-4.8%
Revenue growth (YoY)	+640.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live CRNX data on Nama Insights →

Recent Congressional trades

Crinetics Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 6, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	May 5, 2025
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 6, 2025
Josh Gottheimer	House	Buy	$1,001 - $15,000	Oct 3, 2024